PFM Health Sciences’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-71,800
Closed -$23.9M 86
2024
Q1
$23.9M Buy
+71,800
New +$21.9M 1.13% 33
2020
Q3
Sell
-179,600
Closed -$17.4M 85
2020
Q2
$17.4M Buy
+179,600
New +$18.7M 0.9% 40
2013
Q3
Sell
-431,200
Closed -$345K 82
2013
Q2
$345K Buy
+431,200
New +$16.7M 0.01% 72

Other funds holding HCA

PFM Health Sciences's HCA Position: Q1 2026 in Review

PFM Health Sciences reduced its HCA Healthcare (HCA) stake by 3.7% in Q1 2026, selling an estimated $259K and leaving 13,351 shares worth $6.32M. The position accounts for 0.58% of the portfolio, ranked #56.

PFM Health Sciences first reported a position in HCA in Q2 2013 and has held it in 47 quarters since. The position peaked at $250M in Q1 2014. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • PFM Health Sciences held 13,351 shares of HCA Healthcare worth $6.32M as of Q1 2026.
  • PFM Health Sciences sold 514 HCA Healthcare shares in Q1 2026, an estimated $259K.
  • HCA Healthcare made up 0.58% of PFM Health Sciences's portfolio in Q1 2026, its #56 holding.
  • PFM Health Sciences first reported a position in HCA Healthcare in Q2 2013 and has held it in 47 quarters since.
  • PFM Health Sciences's HCA Healthcare position peaked at $250M in Q1 2014.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.